Esophageal Function Testing and Ambulatory Impedance pH Monitoring The Oregon Clinic GI Division.

Slides:

Advertisements

Similar presentations

ESOPHAGEAL FUNCTION TESTING IN 2011

Advertisements

Fisiopatologia del Reflusso e delle Plastiche Antireflusso XXIV Congr. Naz. ACOI, Montecatini 2005 Sez. Chirurgia Esofago- Gastrica U.Fumagalli I I I C.

Il sottoscritto EDOARDO SAVARINO in qualit à di docente dell evento sopra indicato, ai sensi dell art. 3.3 sul Conflitto di Interessi, pag. 17 del Reg.

Jia-Feng Wu, M.D. Division of Gastroenterology, Department of Pediatrics, National Taiwan University Children Hospital.

Reflux. Common Symptoms Heartburn Globus Chest Pains.

Management of Achalasia

GI Imaging Densities X-ray allows visualization of different densities -Air -Fat -Water -Metal.

Esophageal Motility Disorders

ESOPHAGEAL pH STUDIES IN ESOPHAGEAL DISEASE

1 Literature Review Peter R. McNally, DO, FACP, FACG Lone Tree, Colorado.

Diagnostic Testing: What I Need to Know and When to Order Studies David C. Metz, MD Prof. Medicine Division of Gastroenterology University of Pennsylvania.

Esophageal Motility Disorders

Demonstrate Real-Time HRM Pattern Recognition Intubation Folded Catheter.

Mary Ganley RN BSHA, CGRN April 13,  List indications and contraindications for manometry procedures involving esophagus, stomach, small bowel,

New Developments in Gastroenterology at West Herts High Resolution oesophageal manometry and 24 hour pH studies Dr Mark Fullard Consultant Gastroenterologist.

DYSPHAGIA - THE ROLE OF OESOPHAGEAL MOTILITY DISORDERS IAN WALLACE FCP(SA), FRACP. SHAKESPEARE SPECIALIST GROUP MILFORD, AUCKLAND.

DYSPHAGIA Aswad H. Al.Obeidy FICMS, FICMS GE&Hep Kirkuk General Hospital.

Esophageal Diseases By Dr : RAMY A. SAMY.

Approach to dysphagia. Definition of Dysphagia The word dysphagia is derived from the Greek phagia (to eat) and dys (with difficulty). It specifically.

Gastro-esophageal Reflux Surgical Management Fahad Y. Bamehriz, MBBS, SBIS.

Gastro-Esophageal Reflux Disease

Chhaya Hasyagar, MD Gastroenterology Kaiser, Sacramento

High-Resolution Manometry & 24-hour Reflux Testing Swallowing: One Bite At A Time -or- Don ’ t Bite Off More Than You Can Chew Presented by Ron Turner,

ESOPHAGEAL MOTILITY DISORDERS DR V JONKER DEPT CARDIOTHORACIC SURGERY.

Routine Combined Esophageal Impedance and pH Measurement in Children T. G. Wenzl, M. Welter, E. Berkemeier, G. Heimann Kinderklinik, Universitätsklinikum.

New Techniques and Perspectives Presented on: May 17th 2014

Yuen Soon Oesophagogastric Laparoscopic Physiology.

A gastroenterologist’s view of GERD and its pre-operative workup

Copyright © 2005, Duke Internal Medicine Residency Curriculum and DHTS Technology Education Services Duke Internal Medicine Residency Curriculum Question.

 Case1 :Esophageal Cancer  Diagnosis  Management  Case2 : Achalasia  Diagnosis  Management  Case3 : GERD  Diagnosis  Management.

Gastro Esophageal Reflux Disease Presented for Sherman Hospital By Lawrence R. Kosinski, MD, MBA, FACG March 24 th, 2004.

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors F Zerbib, A Duriez, S Roman, M.

D. Kiagiadaki, V. Bachy, M. Remacle, S. Van Der Vorst, G. Lawson

GI MOTILITY When Slow Doesn’t Always Win the Race

Achalasia: Update on the Disease and Its Treatment

Figure 3 Algorithm from working group describing

Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease Evan S. Dellon, Nicholas J. Shaheen

Achalasia With Dense Eosinophilic Infiltrate Responds to Steroid Therapy Edoardo Savarino, Lorenzo Gemignani, Patrizia Zentilin, Nicola De Bortoli, Alberto.

Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease Evan S. Dellon, Nicholas J. Shaheen

Tracings of concurrent oesophageal manometry, pH, and impedance.

Management of Patients With Functional Heartburn

Figure 4 Examples of reflux episodes on pH and pH-impedance monitoring

Tracings of concurrent oesophageal manometry, pH, and impedance.

Ikuo Hirano, Qing Zhang, John E. Pandolfino, Peter J. Kahrilas

Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

Radu Tutuian, Donald O Castell

Masashi Maeda et al. Heart Asia 2013;5:7-14

Effect of confidence interval reduction to demonstrate a true difference in means. Effect of confidence interval reduction to demonstrate a true difference.

High-Resolution Manometry and Impedance-pH/Manometry: Valuable Tools in Clinical and Investigational Esophagology Peter J. Kahrilas, Daniel Sifrim Gastroenterology

Neeraj Sharma, Amit Agrawal, Janice Freeman, Marcelo F

HRM findings in the two groups (those with delayed GE (blue bars) and those with normal GE (orange bars)), using the Chicago classification (v.3) (see.

Parameters on Esophageal pH-Impedance Monitoring That Predict Outcomes of Patients With Gastroesophageal Reflux Disease Amit Patel, Gregory S. Sayuk,

Efficacy of Esophageal Impedance/pH Monitoring in Patients With Refractory Gastroesophageal Reflux Disease, on and off Therapy Jason M. Pritchett, Muhammad.

Clinical Gastroenterology and Hepatology

Advances in Management of Esophageal Motility Disorders

Approach to the Patient with Dysphagia

A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.

Achalasia: Update on the Disease and Its Treatment

Neeraj Sharma, Amit Agrawal, Janice Freeman, Marcelo F

Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.

Individual data and mean of absolute gall bladder emptying (cm3) induced by modified sham feeding (MSF) in controls and patients with slow transit constipation.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to minimum observed white blood cell.

Cox regression analysis of the proportion of patients remaining in remission during azathioprine treatment related to diagnosis of inflammatory bowel disease.

Cumulative incidence of calcification (A) and diabetes (B) since birth in smokers and non-smokers in chronic alcoholic pancreatitis, and cumulative incidence.

Study protocol. Study protocol. (A) Patients were randomly allocated to placebo or amitriptyline treatment for four weeks. At the end of the month there.

Complete intestinal metaplasia (IM) is characterised by goblet cells stained red or blue by alcian blue (pH 2.5)-periodic acid Schiff stain and by the.

Gall bladder volumes (mean (SEM)) in the fasting state, during, and after modified sham feeding (MSF) and in response to cholecystokinin (CCK) infusion.

(A) Percentage of patients achieving remission or response at week 12 or 24 after initiating ova therapy. (A) Percentage of patients achieving remission.

Presentation transcript:

Esophageal Function Testing and Ambulatory Impedance pH Monitoring The Oregon Clinic GI Division

EFT Cases Total 228 Achalasia 17 Vigorous Achalasia 9 Diffuse Esophageal Spasm 1 Nutcracker Esophagus 23 Ineffective Esophageal Motility (IEM) 71 Hypotensive LES 3 Hypertensive LES 17 Incomplete LES relaxation 37 Cricopharyngeal Achalasia 23 Hypertensive UES 35 Aborted patient intolerance 10 Remainder normal or minor abnormality of bolus transit

Impedance pH testing cases Abnormal acid or non acid reflux 102 Hypersensitive esophagus (normal study except for positive symptom indices) 6 Aborted due to patient intolerance 11

Normal EFT

Normal EFT Contour View

Normal EFT (2)

Normal EFT Contour View (2)

Achalasia

Achalasia Contour View

Achalasia

Achalsaia Contour View

Spasm

Spasm Contour View

Ineffective Esophageal Motility IEM

Acid Reflux

Acid Relux

Acid Reflux

Non Acid Reflux

Symptom-Reflux Association in NERD Patients

Copyright ©2006 BMJ Publishing Group Ltd. Mainie, I et al. Gut 2006;55: Persistent GERD Symptoms despite PPI Therapy